文献速递消化系统肿瘤

肝细胞癌治疗进展:面向临床医生的当前与演变治疗格局概述

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.
PubMed 文献 · CA Cancer J Clin · 2025-05-20

肝细胞癌是全球第六大常见恶性肿瘤和第三大癌症死亡原因。本综述讨论手术切除、移植、局部区域治疗及免疫联合靶向等系统治疗进展,并关注毒性反应与以患者为中心的考量。

要点

  • 系统与局部区域治疗进展改变指南,部分晚期患者经降期后可能接受以治愈为目的的肝部分切除或移植。
  • 综述涵盖切除、移植、栓塞、消融、放疗、肝动脉灌注及免疫联合靶向治疗。
  • 文章同时讨论毒性反应和以患者为中心的考量。

核心结论

  • 系统与局部区域治疗的当代进展已改变同行评议指南中关于系统治疗的内容,并使部分晚期患者经降期后可能接受以治愈为目的的肝部分切除或移植。

研究设计与样本

  • 本综述聚焦肝细胞癌所有治疗模式,在有现代改变实践的随机数据时以其为指导。

主要发现

  • 综述讨论了肝细胞癌的手术管理(包括切除和移植,两者关于生物学可切除和可移植的标准均在演变)以及局部区域治疗(即治疗性栓塞、消融、放疗和肝动脉灌注)。
  • 综述总结了评估晚期疾病免疫联合靶向治疗以及辅助系统治疗的历史性和现代改变实践的试验。
  • 文章还审视了毒性反应和以患者为中心的考量这一关键维度。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer-reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients with advanced disease to ultimately undergo partial hepatectomy or transplantation with curative intent. This review focuses on all modalities of therapy for HCC, guided by modern-day practice-changing randomized data where available. The surgical management of HCC, including resection and transplantation, both of which have evolving criteria for what is considered biologically resectable and transplantable, as well as locoregional therapy (i.e., therapeutic embolization, ablation, radiation, and hepatic arterial infusion), are discussed. Historical and modern-day practice-changing trials evaluating immunotherapy with targeted therapies for advanced disease, as well as adjuvant systemic therapy, are also summarized. In addition, this article examines the critical dimension of toxicities and patient-oriented considerations to ensure a comprehensive and balanced discourse on treatment implications.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Moris D, Martinino A, Schiltz S, et al. Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. CA Cancer J Clin. 2025. PMID: 40392748. doi:10.3322/caac.70018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。